from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2687c/-

LFCtreatmentdescriptionclass of inhibitor

-0.319

Amikacinug/mL Amikacintranslation

-0.683

Cap5-10ug/mL Capreomycintranslation

-0.712

Rox10-50 ug/mL Roxithromycintranslation

-0.474

SM2-5 ug/mL Streptomycintranslation

-0.579

Tet5-10 ug/mL Tetracyclinetranslation

-0.044

Rif0.2-5ug/mL Rifampicintranscription

-1.005

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.877

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.311

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.382

CPZ10-50 ug/mL Chlorpromazinerespiration

0.633

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.444

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.532

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.963

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.112

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.546

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.270

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.387

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.151

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.857

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.195

KCN5-20 ug/mL Potassium cyaniderespiration

-0.357

NaN30.2-2 mM Sodium aziderespiration

0.194

Nigericin50 uM Nigericinrespiration

0.281

TRC10-150 ug/mL Triclosanrespiration

1.921

TRZ10-25 ug/mL Thioridazinerespiration

0.501

Valinomycin0.5-10 uM Valinomycinrespiration

-0.674

ZnSO42 mM ZnSO4respiration

-0.383

menadione6-10 ug/mL Menadionerespiration

0.399

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.657

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.442

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.068

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.228

NRP_1Non-replicating persistence stage 1dosRassociated

-0.362

Amp0.2mg/mL AmpicillincellWall

-0.456

Cephalexin20-100 ug/mL CephalexincellWall

-0.651

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.053

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.057

EMB10-20 ug/mL EthambutolcellWall

-0.443

Eta12-40 ug/mL EthionamidecellWall

-0.321

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.382

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.853

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.749

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.429

BZA0.12 mg/mL BenzamidearomaticAmides

-0.313

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.479

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.285

H2O24 mM hydrogen peroxideDNAdamaging

-0.633

Levo10 ug/mL LevofloxacinDNAdamaging

-0.398

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.548

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.185

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.470

UVUV-irradiationDNAdamaging

0.996

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.292

Antimycin12.5-50 ug/mL Antimycin A?

-0.224

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.077

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.349

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.722

PA8240.2-2 ug/mL PA-824?

0.540

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.315

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.221

Verapamil50 uM Verapamil?

-0.614

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.692

methoxatin10-20 ug/mL Methoxatin?